114 related articles for article (PubMed ID: 20931799)
1. [Differing response to GnRH antagonists in cycles of ovarian hyperstimulation plus intrauterine insemination].
Barros-Delgadillo JC; Trejo-Castañeda H; E-Ormsby C; Gaviño-Gaviño F
Ginecol Obstet Mex; 2010 Jan; 78(1):15-28. PubMed ID: 20931799
[TBL] [Abstract][Full Text] [Related]
2. GnRH antagonist-induced inhibition of the premature LH surge increases pregnancy rates in IUI-stimulated cycles. A prospective randomized trial.
Allegra A; Marino A; Coffaro F; Scaglione P; Sammartano F; Rizza G; Volpes A
Hum Reprod; 2007 Jan; 22(1):101-8. PubMed ID: 17032732
[TBL] [Abstract][Full Text] [Related]
3. The addition of GnRH antagonists in intrauterine insemination cycles: a pilot study.
Graziano A; Caserta D; Piva I; Lo Monte G; Bordi G; Martini F; Tognon M; Marci R
Eur Rev Med Pharmacol Sci; 2013 Jun; 17(12):1604-10. PubMed ID: 23832726
[TBL] [Abstract][Full Text] [Related]
4. Cetrorelix lowers premature luteinization rate in gonadotropin ovulation induction-intrauterine insemination cycles: a randomized-controlled clinical trial.
Steward RG; Gill I; Williams DB; Witz CA; Griffith J; Haddad GF
Fertil Steril; 2011 Jan; 95(1):434-6. PubMed ID: 20810107
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of results of intrauterine insemination performed once or twice per stimulated cycle].
Ruiz Anguas J; Anta Jaen E; Durán Monterrosas L; Kably Ambe A
Ginecol Obstet Mex; 2005 Feb; 73(2):76-82. PubMed ID: 21961341
[TBL] [Abstract][Full Text] [Related]
6. Multifollicular recruitment in combination with gonadotropin-releasing hormone antagonist increased pregnancy rates in intrauterine insemination cycles.
Gómez-Palomares JL; Acevedo-Martín B; Chávez M; Manzanares M; Ricciarelli E; Hernández ER
Fertil Steril; 2008 Mar; 89(3):620-4. PubMed ID: 17678911
[TBL] [Abstract][Full Text] [Related]
7. Homologous intrauterine insemination in controlled ovarian hyperstimulation cycles: a comparison among three different regimens.
Casadei L; Zamaro V; Calcagni M; Ticconi C; Dorrucci M; Piccione E
Eur J Obstet Gynecol Reprod Biol; 2006 Dec; 129(2):155-61. PubMed ID: 16687201
[TBL] [Abstract][Full Text] [Related]
8. Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized study.
Schachter M; Friedler S; Ron-El R; Zimmerman AL; Strassburger D; Bern O; Raziel A
Fertil Steril; 2008 Oct; 90(4):1087-93. PubMed ID: 18023439
[TBL] [Abstract][Full Text] [Related]
9. Advantages of recombinant follicle-stimulating hormone over human menopausal gonadotropin for ovarian stimulation in intrauterine insemination: a randomized clinical trial in unexplained infertility.
Rashidi M; Aaleyasin A; Aghahosseini M; Loloi S; Kokab A; Najmi Z
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):244-7. PubMed ID: 23541417
[TBL] [Abstract][Full Text] [Related]
10. Comparison of different gonadotrophin preparations in intrauterine insemination cycles for the treatment of unexplained infertility: a prospective, randomized study.
Demirol A; Gurgan T
Hum Reprod; 2007 Jan; 22(1):97-100. PubMed ID: 16954409
[TBL] [Abstract][Full Text] [Related]
11. Comparison of controlled ovarian stimulation with human menopausal gonadotropin or recombinant follicle-stimulating hormone.
Filicori M; Cognigni GE; Pocognoli P; Tabarelli C; Ferlini F; Perri T; Parmegiani L
Fertil Steril; 2003 Aug; 80(2):390-7. PubMed ID: 12909504
[TBL] [Abstract][Full Text] [Related]
12. An increased serum progesterone-to-estradiol ratio on the day of human chorionic gonadotropin administration does not have a negative impact on clinical pregnancy rate in women with normal ovarian reserve treated with a long gonadotropin releasing hormone agonist protocol.
Lai TH; Lee FK; Lin TK; Horng SG; Chen SC; Chen YH; Wang PC
Fertil Steril; 2009 Aug; 92(2):508-14. PubMed ID: 18701101
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphene citrate as adjuvants to recombinant follicle-stimulating hormone in controlled ovarian hyperstimulation: a prospective, randomized, blinded clinical trial.
Barroso G; Menocal G; Felix H; Rojas-Ruiz JC; Arslan M; Oehninger S
Fertil Steril; 2006 Nov; 86(5):1428-31. PubMed ID: 16978619
[TBL] [Abstract][Full Text] [Related]
14. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
Humaidan P; Bredkjaer HE; Bungum L; Bungum M; Grøndahl ML; Westergaard L; Andersen CY
Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966
[TBL] [Abstract][Full Text] [Related]
15. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
[TBL] [Abstract][Full Text] [Related]
16. GnRH antagonists in poor responders.
Kolibianakis E; Albano C; Zikopoulos K; Kahn JA; Van Steirteghem A; Devroey P
Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1216-7. PubMed ID: 15548159
[No Abstract] [Full Text] [Related]
17. A spontaneous luteinizing hormone surge is beneficial in women with unexplained infertility undergoing controlled ovarian hyperstimulation without in vitro fertilization.
Costello MF; Hughes GJ; Garrett DK; Hanjani A; Steigrad SJ
Int J Fertil Womens Med; 1998; 43(1):28-33. PubMed ID: 9532467
[TBL] [Abstract][Full Text] [Related]
18. Treatment with the GnRH antagonist ganirelix prevents premature LH rises and luteinization in stimulated intrauterine insemination: results of a double-blind, placebo-controlled, multicentre trial.
Lambalk CB; Leader A; Olivennes F; Fluker MR; Andersen AN; Ingerslev J; Khalaf Y; Avril C; Belaisch-Allart J; Roulier R; Mannaerts B
Hum Reprod; 2006 Mar; 21(3):632-9. PubMed ID: 16361296
[TBL] [Abstract][Full Text] [Related]
19. [Preliminary results of effectiveness of two schemes of controlled ovarian hyperstimulation protocols with recombinant foliculle stimulating hormone in intrauterine insemination cycles].
Barros Delgadillo JC; Fiszman Amora R; Santibañez Morales A; Sánchez Solis V; Gaviño Gaviño F
Ginecol Obstet Mex; 2012 Feb; 80(2):61-72. PubMed ID: 22519213
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive leuprolide therapy does not improve cycle fecundity in controlled ovarian hyperstimulation and intrauterine insemination of subfertile women.
Dodson WC; Walmer DK; Hughes CL; Yancy SE; Haney AF
Obstet Gynecol; 1991 Aug; 78(2):187-90. PubMed ID: 1906152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
